Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity. - Test2 - elhamkhani - TriplyDB

Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity.

Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity.

http://www.wikidata.org/entity/Q34427654

about

Translatability of helminth therapy in inflammatory bowel diseases Nematode modulation of inflammatory bowel disease Potential treatment of inflammatory bowel disease: a review of helminths therapy A Multihit Model: Colitis Lessons from the Interleukin-10-deficient Mouse IL-13 from intraepithelial lymphocytes regulates tissue homeostasis and protects against carcinogenesis in the skin Mechanisms of fibrosis: therapeutic translation for fibrotic disease Infection with murine norovirus 4 does not alter Helicobacter-induced inflammatory bowel disease in Il10(-/-) mice.Worm burden-dependent disruption of the porcine colon microbiota by Trichuris suis infection Association of IL-13 single nucleotide polymorphisms in Iranian patients to multiple sclerosis Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance.IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner.Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3⁺ regulatory T-cell responses in mice.Aqueous Tear Deficiency Increases Conjunctival Interferon-γ (IFN-γ) Expression and Goblet Cell Loss.Therapeutic potential of recombinant cystatin from Schistosoma japonicum in TNBS-induced experimental colitis of mice Irinotecan (CPT-11)-induced elevation of bile acids potentiates suppression of IL-10 expression.IL-13 receptor α2-arginase 2 pathway mediates IL-13-induced pulmonary hypertension.Plasticity within the αβ⁺CD4⁺ T-cell lineage: when, how and what for?STAT6 Signaling Attenuates Interleukin-17-Producing γδ T Cells during Acute Klebsiella pneumoniae Infection.Trichuris muris research revisited: a journey through time IL-13 receptor α2 contributes to development of experimental allergic asthma.T helper cytokines in dry eye disease Inflammatory bowel disease: pathogenesis.Inflamed gut mucosa: downstream of interleukin-10.IL-13 Signaling in Liver Fibrogenesis The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases.The complexity of globus: a multidisciplinary perspective.Type 2 cytokines: mechanisms and therapeutic strategies.IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription 6 activation.Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.Properdin Regulation of Complement Activation Affects Colitis in Interleukin 10 Gene-Deficient Mice.Increased susceptibility to Trichuris muris infection and exacerbation of colitis in Mdr1a-/- mice.Absence of a role for interleukin-13 in inflammatory bowel disease.Astragalus saponin attenuates the expression of fibrosis-related molecules in irradiated cardiac fibroblasts.Old and New Lymphocyte Players in Inflammatory Bowel Disease.Targeting tumour necrosis factor receptor 1 assembly reverses Th17-mediated colitis through boosting a Th2 response.IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis.Pulverized konjac glucomannan ameliorates oxazolone-induced colitis in mice.Type 2 Immune Mechanisms in Carbon Nanotube-Induced Lung Fibrosis.

P2860

Q22252437-68227B97-437C-4EE5-8B75-F35A0B883F50 Q26865117-BE3FC3C1-0E64-4548-A75B-22688D6564B7 Q27027621-19CFB76E-DA01-464D-B566-C95E6C4E7FCB Q28081920-CAC55C35-2392-46E9-A24A-4BCBE8F22F53 Q28831392-7BB5252D-0FE2-4662-A0EB-D20F21E8A278 Q29620307-749F6E74-45A3-443C-BC0A-92D272A9B1FC Q34219244-2C3D37BE-D87E-414F-88FE-6BD6CAE654DA Q34245101-5998F0FD-7FE0-4DB2-81F4-D32AA304E371 Q34987652-399491AF-4F32-414C-AD9F-1BB80D4F7C58 Q35017646-0D9710E6-F526-4319-A00F-6CDAA0113427 Q35685575-7F28A778-9DBA-4077-8DB3-939A7B50A6A1 Q36130948-A8D572FB-24FB-4761-AE92-2B50760DD8C5 Q36345503-D10E89D7-FEF6-4E5C-B5B3-C8D222DEAF91 Q36428563-AB0D714F-5D10-4877-88A5-84A14E13CD67 Q36479746-A42B5B0D-EECC-4353-8659-0B9289950F90 Q36527952-B201EDE7-25F3-46FA-9B07-359965E7137B Q36702429-3B12D1F0-CF15-499F-B69E-38B28803FBFF Q36888504-9652E929-F42C-483D-B4A0-C262110D047A Q37142724-4A70723A-6313-470E-A25E-897828C97F4F Q37333077-E8BC0D68-8445-4E6A-A130-FE673A7DA669 Q37374838-C6EE7CA2-269E-474F-A9C5-506D4AA722D9 Q37454586-D966C2E4-2BAC-4575-BC99-885343CC1EC7 Q37883443-4157EDF0-4753-470A-A582-75F5A6895708 Q38010706-93F5879C-9950-417D-BE0D-462C9B13DD44 Q38132555-B0299C5B-D32D-4C8E-B475-E5D5BF73EF25 Q38168038-4FB0120D-3B46-42EE-A5B7-37A399088AB4 Q38424752-E561EEA9-304C-4298-BC11-604C38F8A32E Q38758144-AFAA058A-4FB1-4526-B30C-68B746FF3370 Q38993044-B0106445-BE11-4719-86E2-97056AC4774A Q41261204-FD41A88A-3406-416A-9B63-37EF89FA6722 Q41969883-8B063A34-427F-4496-B4A5-1946DB96EB69 Q42236791-8AC81833-275B-459C-B274-D69FFB8CBABA Q46904777-DC7868B1-9F01-43CC-AD8A-6971E4841599 Q48351328-54156F27-6C10-4FBE-8C8D-CBB48CF799D2 Q50793590-87A39D46-8060-4E70-8AE7-74E3B0A91596 Q51704712-B6106D6B-FEB3-4C28-A865-15A197EF4C9B Q54722460-78ED31AE-16A1-4F40-87AC-8F8E513A8B6A Q55241957-0F2E58F5-F5F9-4321-8C06-EB60F1304787

P2860

Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity.

http://www.wikidata.org/entity/Q34427654

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Colitis and intestinal inflamm ...... attenuation of IL-13 activity.

@ast

Colitis and intestinal inflamm ...... attenuation of IL-13 activity.

@en

Colitis and intestinal inflamm ...... attenuation of IL-13 activity.

@nl

type

label

Colitis and intestinal inflamm ...... attenuation of IL-13 activity.

@ast

Colitis and intestinal inflamm ...... attenuation of IL-13 activity.

@en

Colitis and intestinal inflamm ...... attenuation of IL-13 activity.

@nl

prefLabel

Colitis and intestinal inflamm ...... attenuation of IL-13 activity.

@ast

Colitis and intestinal inflamm ...... attenuation of IL-13 activity.

@en

Colitis and intestinal inflamm ...... attenuation of IL-13 activity.

@nl

P1433

Q34427654-A68E0626-C8A5-4D9A-AC90-07308AD72AA8

P1476

Q34427654-92B0E4D7-7233-40B9-8971-03AAE4BED35C

P2093

Q34427654-077849E3-3F91-4DF5-8640-BEA857741B6A

Q34427654-0A8C2E76-4578-4A16-AA95-9091F2AE8211

Q34427654-444C3135-1B3F-4FB6-8A21-C57FDD1A4EB5

Q34427654-4BAA3318-9CF9-46D0-8A63-C03DCA934EB3

Q34427654-71390C7C-A3AD-4A43-85C1-A1B6613AECED

Q34427654-73067651-8887-47A1-B6AD-DDC872065D54

Q34427654-B6CB3736-0845-4093-9BD8-B947EBC987F3

Q34427654-F5CDD6EF-C897-4501-A568-37F2FFF021FF

Q34427654-F92DCF8C-7028-401B-875F-E2D598CFEA6C

P2860

Q34427654-00E8E943-F6C5-41A7-A20C-A0B58DCB133E

Q34427654-082F8D38-1727-4F6E-88F3-900078D16FB5

Q34427654-0B5E2E7E-C8D0-4893-B5A2-B42D7E14B209

Q34427654-128EDD3F-036F-4C5A-A43F-59A96D08060F

Q34427654-1CDCF983-2A27-4CD5-AC71-AD3A0CB05D6B

Q34427654-1CEF83AD-E516-43BB-B930-C7731DCE57E4

Q34427654-1EC7068D-0B8D-4643-AF3F-4C1D0031E6B7

Q34427654-26A7B272-DF94-4E02-8C78-266B43689A8E

Q34427654-2E98F4A0-C320-4537-9FF8-69E89CC6E5DC

Q34427654-3183308B-1C35-434B-B21B-966379CA1A4F

P304

Q34427654-5E3767F2-864B-410D-A67A-E89548ACFA40

P31

Q34427654-1304E944-7DB5-4985-94E4-B37DACC8A532

P356

Q34427654-169349CD-D57B-444C-95DE-2A68AFA33735

P407

Q34427654-5EA08C2F-568F-4FD2-A88D-0A67E6F377A1

P433

Q34427654-7CF76F7E-39C3-4AD6-862C-60777BB385B1

P478

Q34427654-540A8253-866E-44D1-82AC-B6F4D3C5FD07

P50

Q34427654-799E9292-F580-4AC3-ABD1-40A35098ACCF

P577

Q34427654-67CD12D0-1F82-43E4-86CD-D6E6B16BA8D3

P5875

Q34427654-2108148D-51F1-470C-A74B-B038CCF7DA8B

P698

Q34427654-22E8A92D-1A07-4ADB-815D-D2D9AA3E4408

P932

Q34427654-BA0BB6AC-A460-4214-BFB1-A2EE2859AC69

P356

J.GASTRO.2010.09.047

P1433

Gastroenterology

P1476

Colitis and intestinal inflamm ...... attenuation of IL-13 activity

@en

P2093

Allen W Cheever

http://www.w3.org/2001/XMLSchema#string

Brian L Kelsall

http://www.w3.org/2001/XMLSchema#string

David Artis

http://www.w3.org/2001/XMLSchema#string

Kevin Shenderov

http://www.w3.org/2001/XMLSchema#string

Margaret M Mentink-Kane

http://www.w3.org/2001/XMLSchema#string

Mark S Wilson

http://www.w3.org/2001/XMLSchema#string

Satish K Madala

http://www.w3.org/2001/XMLSchema#string

Thirumalai R Ramalingam

http://www.w3.org/2001/XMLSchema#string

Thomas A Wynn

http://www.w3.org/2001/XMLSchema#string

P2860

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses

Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function

IL-13 effector functions

Interleukin-13: central mediator of allergic asthma

Interleukin-10-deficient mice develop chronic enterocolitis

Increased expression of interleukin 17 in inflammatory bowel disease

The role of IL-10 in inflammatory bowel disease: "of mice and men".

An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.

Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13.

Crohn's disease and ulcerative colitis in the same patient

P304

254-264

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2010.09.047

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

140

http://www.w3.org/2001/XMLSchema#string

P50

Aymeric Rivollier

P577

2010-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47448451

http://www.w3.org/2001/XMLSchema#string

P698

20951137

http://www.w3.org/2001/XMLSchema#string

P932

3006653

http://www.w3.org/2001/XMLSchema#string